A Phase 1, Open-label, Two-period, Single-sequence Study to Evaluate the Effect of Rifampin on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Tivozanib in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2012
At a glance
- Drugs Rifampicin; Tivozanib
- Indications Bacterial infections; Cancer
- Focus Adverse reactions; Pharmacokinetics
- 04 Jun 2012 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 04 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2011 New trial record